Glade Brook Capital
80 Field Point Road, Greenwich, CT, 06830, UNITED STATES
Overview
Glade Brook Capital Partners focuses on companies in the technology, media, telecom, and consumer sectors. Glade Brook specializes in technology growth equity, the Firms' experience investing across private and public markets, and a network of company management teams, entrepreneurs, and industry leaders foster unique deal flow. It was founded in 2011 by Paul Hudso.
- Total investments
- 44
- Lead investments
- 19
- Investments · 12mo
- 13
- Active investors
- 8
Sector focus
- Finance
- Financial Exchanges
- Financial Services
- Venture Capital
Investment portfolio
- Sarvam AI
Participated · Series B · Aug 2026
Sarvam AI is developing a sovereign AI architecture aimed at India, creating specialized large models and a reasoning layer tailored for native languages and high-security use cases. The company is producing models such as Sarvam-30B and a defense-grade platform called Chanakya, and is positioned to serve government departments and global enterprises targeting next‑billion users. Its technical roadmap leverages a government-backed allocation of 4,096 NVIDIA H100 GPUs under the IndiaAI Mission. Co-founders Vivek Raghavan and Pratyush Kumar lead the initiative, and the company emphasizes India-centric intelligence and multilingual enterprise agility. Financially, Sarvam is closing a $300–350 million funding round at a $1.5 billion valuation led by Bessemer Venture Partners with strategic backing from NVIDIA, Amazon, and Prosperity7.
- CuspAI
Participated · Series B · Jul 2026
CuspAI builds AI systems that search for and design new materials tailored to specified properties, serving customers including ASML and Meta. The company counts AI researchers Yann LeCun and Geoffrey Hinton as advisers. It plans to expand geographically across the US, APAC and Europe and to deploy an “AI Materials Foundry,” a global network of data, labs, compute and scientific expertise with founding partners such as Nvidia, Meta, Samsung and Hyundai and more than 40 other companies. Financially, CuspAI is a two-year-old startup that has raised over $670M to date, including a $450M Series B that values it at $2.6B. The firm says its platform addresses materials discovery bottlenecks across industries including energy, semiconductors, manufacturing, water treatment and carbon capture.
- TerraFirma
Participated · Series A · Jul 2026
Founded in 2024 by former SpaceX engineers Noah Schochet and Noah McGuinness, TerraFirma builds a full-stack platform that combines AI-enabled pre-construction software, a remote command-and-control center, and retrofitted semi-autonomous heavy machinery for earthworks and site operations. The company's systems let skilled operators orchestrate fleets from screens, which TerraFirma says can make each operator up to 300% more effective. TerraFirma is executing commercial projects including site preparation, excavation, and grading for a Starbucks in North Austin, a sports arena in Spicewood, and a power substation in New Braunfels, and it is working with the U.S. government on international infrastructure and logistics projects. The company is vertically integrated, building and using its own robotics and software in the field while keeping operators at the center. TerraFirma has stated a long-term ambition to extend its construction technology to lunar and Martian projects as well as scale on Earth. Financially, TerraFirma announced approximately $115 million in new capital, including a $100 million Series A, to expand engineering, manufacturing, operations, and continued development of its semi-autonomous equipment.
- Chai Discovery
Participated · Series C · Jul 2026
Chai Discovery develops AI models that reason about biological structure and function to generate new molecular designs from scratch and put those models into a software platform used by pharma teams. The company reports partnerships and deployments with major pharmaceutical firms, including Eli Lilly and Pfizer. Its model lineup includes Chai-2, released in 2025 as the first zero-shot generative platform for fully de novo antibody design to achieve double-digit experimental success rates, and Chai-3, which materially improves target success rates and binding affinity versus its predecessor. Founded in 2024 and based in San Francisco, Chai aims to bring engineering precision, speed and scale to pre-clinical discovery. The company recently raised $400M in a Series C at a $3.8B valuation to accelerate R&D, deployment and partnerships.
- Apex
Led · Equity · Jun 2026
Apex focuses on satellite manufacturing, including building satellite buses for different payloads. The company plans to use the proceeds from its latest funding to expand those manufacturing capabilities. Founded in 2022, Apex also participates in a collaboration on a missile defense project, indicating activity in the defense sector. Its valuation doubled to $2.3 billion following the recent raise of over $200 million. The article does not provide revenue, user metrics, or prior funding specifics.